Numerical study of the bolt-grout interface for fully grouted rockbolt under different confining conditions von Ho, D.-A., Bost, M., Rajot, J.-P.

Volltext

Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study von Rieger, M., Österborg, A., Pettengell, R., White, D., Gill, D., Walewski, J., Kuhnt, E., Loeffler, M., Pfreundschuh, M., Ho, A.D.

Volltext

The impact of CD34+ cell dose on engraftment after SCTs: personalized estimates based on mathematical modeling von Stiehl, T, Ho, A D, Marciniak-Czochra, A

Volltext

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma von Lisenko, K, Dingeldein, G, Cremer, M, Kriegsmann, M, Ho, A D, Rieger, M, Witzens-Harig, M

Volltext

Heterogeneity of mesenchymal stromal cell preparations von Ho, A.D, Wagner, W, Franke, W

Volltext

Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit von Lehners, N, Schnitzler, P, Geis, S, Puthenparambil, J, Benz, M A, Alber, B, Luft, T, Dreger, P, Eisenbach, C, Kunz, C, Benner, A, Buchholz, U, Aichinger, E, Frank, U, Heeg, K, Ho, A D, Egerer, G

Volltext

VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma von Beckermann, B M, Kallifatidis, G, Groth, A, Frommhold, D, Apel, A, Mattern, J, Salnikov, A V, Moldenhauer, G, Wagner, W, Diehlmann, A, Saffrich, R, Schubert, M, Ho, A D, Giese, N, Büchler, M W, Friess, H, Büchler, P, Herr, I

Volltext

Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation von Xu, J, Pfarr, N, Endris, V, Mai, E K, Md Hanafiah, N H, Lehners, N, Penzel, R, Weichert, W, Ho, A D, Schirmacher, P, Goldschmidt, H, Andrulis, M, Raab, M S

Volltext

Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment von Fiehn, C, Hajjar, Y, Mueller, K, Waldherr, R, Ho, A D, Andrassy, K

Volltext

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide von Kayser, S, Krzykalla, J, Elliott, M A, Norsworthy, K, Gonzales, P, Hills, R K, Baer, M R, Ráčil, Z, Mayer, J, Novak, J, Žák, P, Szotkowski, T, Grimwade, D, Russell, N H, Walter, R B, Estey, E H, Westermann, J, Görner, M, Benner, A, Krämer, A, Smith, B D, Burnett, A K, Thiede, C, Röllig, C, Ho, A D, Ehninger, G, Schlenk, R F, Tallman, M S, Levis, M J, Platzbecker, U

Volltext

Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents von Merz, M., Neben, K., Raab, M.S., Sauer, S., Egerer, G., Hundemer, M., Hose, D., Kunz, C., Heiß, C., Ho, A.D., Goldschmidt, H., Hillengass, J.

Volltext

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program von P McLaughlin, A J Grillo-López, B K Link, R Levy, M S Czuczman, M E Williams, M R Heyman, I Bence-Bruckler, C A White, F Cabanillas, V Jain, A D Ho, J Lister, K Wey, D Shen, B K Dallaire

Volltext

Centrosome replication, genomic instability and cancer von KRÄMER, A, NEBEN, K, HO, A. D

Volltext

Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mo... von Fruehauf, S, Ehninger, G, Hübel, K, Topaly, J, Goldschmidt, H, Ho, A D, Müller, S, Moos, M, Badel, K, Calandra, G

Volltext

Evidence of a Graft-Versus-Leukemia Effect in Chronic Lymphocytic Leukemia After Reduced-Intensity Conditioning and Allogeneic Stem-Cell Transplantation: The Cooperative German Tra... von SCHETELIG, J, THIEDE, C, HELD, T. K, HÖFFKEN, K, HO, A. D, KIENAST, J, NEUBAUER, A, ZANDER, A. R, FAUSER, A. A, EHNINGER, G, SIEGERT, W, BORNHÄUSER, M, SCHWERDTFEGER, R, KIEHL, M, BEYER, J, SAYER, H. G, KRÖGER, N, HENSEL, M, SCHEFFOLD, C

Volltext

Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma von Lisenko, K, McClanahan, F, Schöning, T, Schwarzbich, M A, Cremer, M, Dittrich, T, Ho, A D, Witzens-Harig, M

Volltext

Angiogenesis in hematologic malignancies von Moehler, T.M, Ho, A.D, Goldschmidt, H, Barlogie, B

Volltext

The impact of allogeneic stem cell transplantation on the natural course of poor-risk chronic lymphocytic leukemia as defined by the EBMT consensus criteria: a retrospective donor... von Herth, I., Dietrich, S., Benner, A., Hegenbart, U., Rieger, M., Stadtherr, P., Bondong, A., Tran, T.H., Weide, R., Hensel, M., Knauf, W., Franz-Werner, J., Welslau, M., Procaccianti, M., Görner, M., Meissner, J., Luft, T., Schönland, S., Witzens-Harig, M., Zenz, T., Ho, A.D., Dreger, P.

Volltext

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis von Seckinger, A, Meißner, T, Moreaux, J, Goldschmidt, H, Fuhler, G M, Benner, A, Hundemer, M, Rème, T, Shaughnessy, J D, Barlogie, B, Bertsch, U, Hillengass, J, Ho, A D, Pantesco, V, Jauch, A, De Vos, J, Rossi, J F, Möhler, T, Klein, B, Hose, D

Volltext

Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure von Breitkreutz, I, Heiss, C, Perne, A, Beimler, J, Jäger, D, Egerer, G, Ho, A D, Neben, K, Zeier, M, Goldschmidt, H, Raab, M S

Volltext